Riskpilot← Back to searchSign inGet full accessFöretagshälsan i Väst AB
ABActiveOrg 5592492671Forstenagatan 7Computer programming activities · NACE 6210Est. 20200 employees
Revenue 2024
SEK 20K
-7% vs 2023
EBITDA margin
-23.1%
+74% vs 2023
Equity ratio
54.9%
Financial strength
Net profit 2024
SEK -44K
+29% vs 2023
| Revenue | SEK 20K | -7% |
| EBITDA | SEK -5K | +74% |
| Net profit | SEK -44K | +29% |
| Total assets | SEK 36K | -49% |
| Equity | SEK 20K | +48% |
| Employees | 0 | — |
Legal name
Företagshälsan i Väst AB
Org number
5592492671
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
23 mars 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva företagshälsovård, friskvård, hälsovård, sjukvård samt ävensom idka därmed förenlig verksamhet. Vidare ska bolaget bedriva vaccinationsverksamhet och intygsmottagning samt även idka därmed förenlig verksamhet inom ovan nämnda områden. Allmän öppen hälso- och sjukvård.
Address
Forstenagatan 7
Email
semir.f@fluddevalla.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 | 8 | 31 | 21 | 20 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 7 | −36 | −10 | −18 | −5 |
| Depreciation & amort. | −15 | −49 | −49 | −44 | −39 |
| EBIT | −8 | −85 | −59 | −62 | −44 |
| Net financials | −5 | −6 | −1 | −0 | −0 |
| Profit before tax | −14 | −91 | −60 | −62 | −44 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −14 | −91 | −60 | −62 | −44 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 232 | 169 | 116 | 70 | 36 |
| Equity | 111 | 20 | −5 | 13 | 20 |
| Long-term debt | 35 | 147 | 120 | 55 | 14 |
| Short-term debt | 86 | 1 | 2 | 1 | 2 |
| Total debt | 121 | 148 | 122 | 56 | 16 |
EBITDA margin
-23.1%
This company
15.8%
Market median
-246% vs market
20202024
Equity ratio
54.9%
This company
38.2%
Market median
+44% vs market
20202024
Return on equity
-222.0%
This company
18.4%
Market median
-1307% vs market
20202024
Net profit margin
-218.2%
This company
8.1%
Market median
-2794% vs market
20202024
Asset turnover
0.56×
This company
1.12×
Market median
-50% vs market
20202024
Debt / equity
0.82×
This company
0.62×
Market median
+32% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-03-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
RP Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 – 2025 |
JJ Chief Executive Officer | Chief Executive Officer | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Chairman | 2020 – 2025 | |
| Board of Directors | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Företagshälsan i Väst AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Robin Per Nurmisto | Deputy Chief Executive Officer | 0 companies |
| Joel Johannes Olsson | Chief Executive Officer | 0 companies |
| AnnaLinnea Saga D Sjöberg | Chairman | 0 companies |
| Naseer Ahmed | Deputy Board Member | 0 companies |
| Hanna Lovisa Elisabet Nurmisto | Board of Directors | 0 companies |
| Semir Facic | Board of Directors | 0 companies |